Zepp Health reported a gross margin of 37.35% and a net margin of -15.82% for the quarter ended Jun 2026. These financial ratios cover 39 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||
| Gross Margin | 20.16% | 19.30% | 20.11% | 17.90% | 19.13% | 20.70% | 15.94% | 21.99% | 33.89% | 34.74% | 36.79% | 40.26% | 40.61% | 36.83% | 37.27% | 36.18% | 38.16% | 40.41% | 37.71% | 37.35% | |||||||||||||||||||
| EBT Margin | 4.93% | 1.64% | -18.63% | -8.64% | -4.73% | -4.71% | -20.76% | -8.36% | 4.72% | 3.63% | -33.63% | -18.56% | -24.27% | -11.29% | -42.65% | -7.68% | 1.22% | -2.27% | -30.47% | -16.00% | |||||||||||||||||||
| EBIT Margin | 3.87% | 0.61% | -20.51% | -10.14% | -6.32% | -6.62% | -23.48% | -11.18% | 1.80% | 0.89% | -39.81% | -24.27% | -29.53% | -15.01% | -47.68% | -10.27% | -1.17% | -4.55% | -34.32% | -19.37% | |||||||||||||||||||
| EBITDA Margin | 3.87% | 0.61% | -20.51% | -10.14% | -6.32% | -6.62% | -23.48% | -11.18% | 1.80% | 0.89% | -39.81% | -24.27% | -29.53% | -15.01% | -47.68% | -10.27% | -1.17% | -4.55% | -34.32% | -19.37% | |||||||||||||||||||
| Operating Margin | 3.89% | 0.61% | -20.53% | -9.98% | -6.08% | -6.62% | -23.39% | -11.24% | 1.66% | 0.75% | -39.82% | -24.27% | -29.53% | -15.01% | -47.68% | -10.27% | -1.17% | -4.55% | -34.32% | -19.37% | |||||||||||||||||||
| Net Margin | 5.32% | 1.68% | -20.84% | -9.84% | -7.63% | -4.94% | -24.61% | -10.15% | 4.80% | 6.98% | -33.45% | -18.45% | -24.27% | 11.51% | -42.36% | -7.27% | 1.37% | 0.16% | -30.06% | -15.82% | |||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 199.76M | 196.36M | 218.43M | 233.86M | 209.80M | 168.50M | 130.08M | 109.44M | 105.13M | 95.78M | 78.26M | 72.36M | 74.24M | 66.68M | 60.46M | 72.02M | 83.79M | 80.22M | 67.80M | 62.64M | |||||||||||||||||||
| Assets AverageAssets Avg. | 965.71M | 948.97M | 941.74M | 921.31M | 864.64M | 779.48M | 727.00M | 696.60M | 671.14M | 644.55M | 605.04M | 580.29M | 582.99M | 533.86M | 567.70M | 575.63M | 548.72M | 546.13M | |||||||||||||||||||||
| Invested CapitalInvested Cap. | 668.82M | 633.49M | 419.00M | 445.38M | 382.64M | ||||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 1.05 | 1.02 | 0.97 | 0.86 | 0.83 | 0.78 | 0.80 | 0.73 | 0.63 | 0.55 | 0.49 | 0.43 | 0.35 | 0.37 | 0.41 | 0.45 | 0.50 | 0.51 | |||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -4.63 | -0.70 | 13.32 | 7.83 | 4.85 | 4.40 | 11.33 | 5.88 | -0.93 | -0.51 | 10.97 | 7.18 | 9.73 | 6.18 | 13.53 | 4.90 | 0.60 | 2.40 | 10.70 | 7.33 | |||||||||||||||||||
| Debt Ratio | 0.19 | 0.22 | 0.02 | 0.03 | 0.06 | 0.35 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | 0.13 | 0.15 | 0.16 | 0.17 | 0.30 | 0.21 | 0.20 | ||||||||||||||||||||
| Times Interest Earned | -4.63 | -0.70 | 13.32 | 7.83 | 4.85 | 4.40 | 11.33 | 5.88 | -0.93 | -0.51 | 10.97 | 7.18 | 9.73 | 6.18 | 13.53 | 4.90 | 0.60 | 2.40 | 10.70 | 7.33 | |||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 37.88 | 73.37 | -7.34 | -7.21 | -6.72 | -12.19 | -3.66 | -7.84 | 18.60 | 15.99 | -4.98 | -5.22 | -6.89 | 6.20 | -2.97 | -10.07 | 720.57 | 0.00M | -13.05 | -8.77 | |||||||||||||||||||
| Price to SalesP/S | 2.01 | 1.23 | 1.53 | 0.71 | 0.51 | 0.60 | 0.90 | 0.80 | 0.89 | 1.12 | 1.67 | 0.96 | 1.67 | 0.71 | 1.26 | 0.73 | 9.88 | 5.35 | 3.92 | 1.39 | |||||||||||||||||||
| Price to BookP/B | 0.70 | 0.25 | 0.27 | 0.17 | 2.12 | ||||||||||||||||||||||||||||||||||
| Enterprise Value | 309.15M | 92.07M | 16.06M | -32.96M | -56.11M | -41.51M | -60.33M | -74.87M | -56.80M | -42.57M | -64.75M | -84.22M | -48.10M | -67.08M | -29.02M | -12.96M | 685.93M | 342.90M | 149.80M | 18.49M | |||||||||||||||||||
| EV to EBIT | 32.01 | 58.31 | -0.66 | 1.97 | 5.24 | 4.03 | 2.73 | 7.25 | -37.90 | -57.44 | 4.07 | 8.54 | 3.84 | 7.50 | 1.58 | 2.12 | -775.93 | -88.58 | -8.47 | -1.50 | |||||||||||||||||||
| EV to EBITDA | 32.01 | 58.31 | -0.66 | 1.97 | 5.24 | 4.03 | 2.73 | 7.25 | -37.90 | -57.44 | 4.07 | 8.54 | 3.84 | 7.50 | 1.58 | 2.12 | -775.93 | -88.58 | -8.47 | -1.50 | |||||||||||||||||||
| Market Capitalization | 502.17M | 320.49M | 182.78M | 117.41M | 86.95M | 93.60M | 84.57M | 73.59M | 74.24M | 92.67M | 66.56M | 39.16M | 70.97M | 42.52M | 48.41M | 43.50M | 748.67M | 455.84M | 202.20M | 88.16M | |||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 3.87% | 0.61% | -20.51% | -10.14% | -6.32% | -6.62% | -23.48% | -11.18% | 1.80% | 0.89% | -39.81% | -24.27% | -29.53% | -15.01% | -47.68% | -10.27% | -1.17% | -4.55% | -34.32% | -19.37% | |||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 3.58% | 2.38% | -0.36% | -5.16% | -8.84% | -11.43% | -10.84% | -10.48% | -8.18% | -6.13% | -5.39% | -6.10% | -10.51% | -16.09% | -12.17% | -10.12% | -11.22% | -15.00% | |||||||||||||||||||||
| Return on Assets [ROA]ROA | 4.61% | 2.72% | 0.84% | -2.56% | -5.75% | -7.93% | -8.26% | -7.63% | -5.39% | -3.52% | -2.14% | -1.91% | -4.35% | -4.51% | -2.25% | -3.38% | -3.40% | -4.46% |